Coles Cites `Astounding Results’ From Nexavar Tests: Video

Dec 16 Bloomberg — Anthony Coles chief executive officer of Onyx Pharmaceuticals Inc talks with Bloomberg s Pimm Fox about tests Onyx says show their Nexavar pill extended the lives of women with advanced breast cancer Tumors in two-thirds of women treated with Nexavar and paclitaxel shrank by at least 25 percent and were stable for an average of 8 1 months according to results presented at the San Antonio Breast Cancer Symposium an international gathering Source Bloomberg